Long-term prognostic value of cardiopulmonary exercise testing in patients with hypertrophic cardiomyopathy
In this long follow-up study, CPET is a powerful prognostic tool in HCM. A reduced peak VO2 identifies those at higher risk, highlighting the potential for CPET to improve risk stratification, even among patients classified as NYHA Class I.
Authors
- Salvatore Napoli (ORCID: https://orcid.org/0000-0002-8284-2898)
- Grazia Canciello (ORCID: https://orcid.org/0000-0002-1546-1737)
- Roberto Polizzi
- Leopoldo Ordine (ORCID: https://orcid.org/0009-0009-5877-2090)
- Giulia Esposito (ORCID: https://orcid.org/0000-0003-0671-6504)
- P. Daniela
- Raffaella Lombardi
Institutions
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2026-01-08
- DOI
- https://doi.org/10.1093/eschf/xvag013
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00